Argus Positive on United Therapeutics Corp. (UTHR), 'Discounted price offers buying opportunity'

September 22, 2022 6:52 AM EDT Send to a Friend
Argus analyst Jasper Hellweg reiterated a Buy rating and $250.00 price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login